Drug Database
Back to search

Switzerland· 57633004

Caduet

A atorvastatin and amlodipine product containing amlodipinum, atorvastatinum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 7 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C10BX03

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedCaduetATCC10BX03REGISTER NO.57633004PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about amlodipinum, atorvastatinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Atorvastatin and amlodipine is registered in 7 of 19 countries.

Countries holding a registration under ATC C10BX03 (atorvastatin and amlodipine), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 6 of them publish a price we can compare per daily dose
Search atorvastatin and amlodipine products by name

Atorvastatin and amlodipine · ATC C10BX03

7 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
amlodipinum, atorvastatinum
Manufacturer
—
Country
Switzerland (CH)
ATC code
C10BX03
ATC class
Atorvastatin and amlodipine
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680576330041
    98 Stk
    CHF 76.9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for atorvastatin and amlodipine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check atorvastatin and amlodipine against other medicinesHow interaction checks work

Atorvastatin and amlodipine · interactions on record

4 records

4 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Atorvastatin and amlodipine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All atorvastatin and amlodipine products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Atorvalan Comp., Caduet
  • Bulgaria · Амлатор, Атордапин
  • Czechia · Amlator, Caduet
  • Germany · Amloator
  • Spain · Amlodipino/Atorvastatina Krka, Amlodipino/Atorvastatina Normon
  • France · Amlodipine/Atorvastatine Viatris, Caduet
  • Croatia · Atordapin, Caduet
  • Hungary · Amlator, Caduet
  • Lithuania · Atordapin
  • Latvia · Atordapin, Caduet
  • Poland · Amlator
  • Portugal · Caduet, Trinalion
  • Romania · Caduet, Lirtonen
  • Slovenia · Amaloris, Lirtonen
  • Slovakia · Amlator, Dicartil

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/46e37cd0-4fd7-4ae3-89a6-0bfbcc04e172
GET /v1/drugs/46e37cd0-4fd7-4ae3-89a6-0bfbcc04e172?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "amlodipinum 5 mg + atorvastatinum 10 mg",
  "valid_from": "2006-12-01",
  "limitations": "[{\"description\":\"Nur für bereits mit der Kombination der Monopräparate eingestellte Patientinnen und Patienten, welche die Kriterien entsprechend der Limitierung der Atorvastatin-Monopräparate erfüllen.\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2022-08-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 5mg/10mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2006-12-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about atorvastatin and amlodipine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console